BZA-DRUG (PH NO.:25116) BORTEZUMAB 2 MG INJ
STORES/SOUTH CENTRAL RLY · Pharmaceuticals · open
Key facts
- Published: 30 Jul 2026
- Closing date: 07 Sep 2026
- Status: open
Description
Tender for supply of Bortezumab 2 mg injection for South Central Railway, with a closing date of 07/09/2026, limited tender type, estimated quantity 45 units, no EMD or tender cost, governed by IRS conditions, and specific eligibility and compliance conditions.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
- Documents required: Railway Board approved product list, valid import license (if imported), product packaging with indelible ink, MRP and Brand Name details, composition details, full postal address of supply source
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Single Packet
- Evaluation: Itemwise/Consigneewise
- Make in India (MII): No
- MSE preference: No
Line items (1)
- Bortezumab 2 mg injection — Qty: 45 Numbers
5 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals